Simulations Plus Reports Fourth Quarter and Fiscal Year 2007 Preliminary Revenues
Another New Record Set for Quarterly and Annual Revenues
U.S. National Institutes of Health Licenses Simulations Plus’ ClassPharmer™ Software
Another Government Agency Licenses Key Software Product
U.S. FDA Expands Simulations Plus Software Licenses
GastroPlus and DDDPlus Licenses Added
Simulations Plus Releases Unique Dna Mutation Predictor
New Software Screening Tool Helps Pharmaceutical Chemists Predict Drug-Caused DNA Mutations
Simulations Plus Releases Admet Predictor™ Version 2.3
Predictive Accuracy and User Convenience of Best-in-Class Software Now Further Improved
Simulations Plus Reports Third Quarter FY2007 Financial Results
Third Quarter Surpasses Previous Record in Second Quarter
Simulations Plus Announces Third Quarter Fiscal Year 2007 Earnings Conference Call
Conference Call to be on Thursday, July 5, at 4:15 PM EDT
Simulations Plus Wins Small Business Innovation Research (SBIR) Grant
Grant Funds to Speed Commercialization of Improvements to Company's Industry-Leading Molecular Property Prediction Software
Simulations Plus Announces Second Quarter Fiscal Year 2007 Earnings Conference Call
Conference Call to be on Wednesday, April 25, at 4:15 PM EDT
Simulations Plus Reports Second Quarter FY2007 Financial Results
First Six Months' Revenues up 73% and Earnings Jump 1384%
Simulations Plus Extends Its Software Product Line Into Molecular Drug Design
Unique Computer Aided Drug Design Capability Added To Company's ClassPharmer™ Software
Updated Guidance Provided for Fiscal Year 2007 Revenues
Simulations Plus Reports Results Of Annual Meeting
Top 5 Pharmaceutical Company Signs Five-Year Extension Of Services Agreement With Simulations Plus
Contract Signals Long-Term Demand for Simulations Plus' Software and Consulting Services
ANTI-HIV Predictive Models Released by Simulations Plus
Extensions to ADMET Predictor(™) Software Enhance Anti-HIV Activity Discovery Capabilities
Simulations Plus Reports First Quarter FY2007 Financial Results
Record First Quarter Sees Pharmaceutical Revenues Jump 314%
Simulations Plus Announces First Quarter Fiscal Year 2007 Earnings Conference Call
Conference Call to be on Tuesday, January 16, at 4:15 PM EST